Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 6, 2019
Detection of Novel NRG1, EGFR, and MET Fusions in Lung Adenocarcinomas in the Chinese PopulationYunjian Pan, Yang Zhang, Ting Ye, et al.
Oncotargets and Therapy|March 9, 2016
The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populationsDifan Zheng, Rui Wang, Yang Zhang, et al.
International Journal of Cancer|March 7, 2019
tRNA-based prognostic score in predicting survival outcomes of lung adenocarcinomasMuyu Kuang, Difan Zheng, Xiaoting Tao, et al.
American Journal of Clinical Pathology|May 11, 2018
Clinical Significance of Complex Glandular Patterns in Lung Adenocarcinoma: Clinicopathologic and Molecular Study in a Large Series of CasesMuyu Kuang, Xuxia Shen, Chongze Yuan, et al.
Journal of Thoracic Disease|February 13, 2019
A model based on endoscopic morphology of submucosal esophageal squamous cell carcinoma for determining risk of metastasis on lymph nodesLingdun Zhuge, Shengfei Wang, Juntao Xie, et al.
Journal of Thoracic Disease|September 22, 2017
Unique distribution of programmed death ligand 1 (PD-L1) expression in East Asian non-small cell lung cancerYunjian Pan, Difan Zheng, Yuan Li, et al.
Journal of Cancer Research and Clinical Oncology|December 12, 2018
Preoperative brain MRI for clinical stage IA lung cancer: is routine scanning rational?Lingdun Zhuge, Yangle Huang, Shengfei Wang, et al.
Journal of Cancer Research and Clinical Oncology|October 14, 2017
Are exon 19 deletions and L858R different in early stage lung adenocarcinoma?Yiliang Zhang, Yuan Ma, Yuan Li, et al.
Annals of Surgical Oncology|July 24, 2015
Prevalence and Clinicopathological Characteristics of BRAF Mutations in Chinese Patients with Lung AdenocarcinomaDifan Zheng, Rui Wang, Yunjian Pan, et al.
Pageof 5